SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $37.95 million. The enterprise value is -$14.98 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 37.95 million shares outstanding. The number of shares has decreased by -1.25% in one year.
| Current Share Class | 37.95M |
| Shares Outstanding | 37.95M |
| Shares Change (YoY) | -1.25% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 34.66% |
| Float | 31.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.64 |
| Forward PS | 1.35 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.27.
| Current Ratio | 3.13 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.35 |
Financial Efficiency
Return on equity (ROE) is -48.42% and return on invested capital (ROIC) is -36.55%.
| Return on Equity (ROE) | -48.42% |
| Return on Assets (ROA) | -26.72% |
| Return on Capital (ROIC) | -36.55% |
| Revenue Per Employee | $295,379 |
| Profits Per Employee | -$1.26M |
| Employee Count | 29 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SCYNEXIS has paid $266,000 in taxes.
| Income Tax | 266,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.37% in the last 52 weeks. The beta is 1.52, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -47.37% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 29.54 |
| Average Volume (20 Days) | 214,387 |
Short Selling Information
The latest short interest is 795,428, so 2.10% of the outstanding shares have been sold short.
| Short Interest | 795,428 |
| Short Previous Month | 837,550 |
| Short % of Shares Out | 2.10% |
| Short % of Float | 2.55% |
| Short Ratio (days to cover) | 5.04 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $8.57 million and -$36.44 million in losses. Loss per share was -$0.78.
| Revenue | 8.57M |
| Gross Profit | -6.12M |
| Operating Income | -52.93M |
| Pretax Income | -34.72M |
| Net Income | -36.44M |
| EBITDA | -52.37M |
| EBIT | -52.93M |
| Loss Per Share | -$0.78 |
Full Income StatementBalance Sheet
The company has $68.83 million in cash and $15.90 million in debt, giving a net cash position of $52.93 million or $1.39 per share.
| Cash & Cash Equivalents | 68.83M |
| Total Debt | 15.90M |
| Net Cash | 52.93M |
| Net Cash Per Share | $1.39 |
| Equity (Book Value) | 58.53M |
| Book Value Per Share | 1.54 |
| Working Capital | 54.74M |
Full Balance SheetCash Flow
| Operating Cash Flow | -21.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | -21.84M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
| Gross Margin | -71.42% |
| Operating Margin | -617.90% |
| Pretax Margin | -422.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |